Eagle Equity Partners Iii, Llc Insider Trades

Insider Trading History

Track insider trading activity for Eagle Equity Partners Iii, Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $157M 17,325,000 shares
Last Trade
Sep 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$879M 1,925,000 shares
$456.80
$9.05
Soaring Eagle Acquisition - Warrants (23/02/2026)
Soaring Eagle Acquisition - Warrants (23/02/2026) SRNGW
10% owner
Holding Value $52.3M 17,325,000 shares
Last Trade
Sep 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.81M 1,925,000 shares
$3.02
$3.02
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $174M 19,250,000 shares
Last Trade
Sep 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.79B 19,250,000 shares
$456.80
$9.05
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.7B 43,125,000 shares
$456.80
$9.05
Soaring Eagle Acquisition - Warrants (23/02/2026)
Soaring Eagle Acquisition - Warrants (23/02/2026) SRNGW
10% owner
Holding Value $58.1M 19,250,000 shares
Last Trade
Sep 16, 2021 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.1M 19,250,000 shares
$3.02
$3.02
Soaring Eagle Acquisition - Warrants (23/02/2026)
Soaring Eagle Acquisition - Warrants (23/02/2026) SRNGW
10% owner
Holding Value $0 0 shares
Last Trade
Sep 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130M 43,125,000 shares
$3.02
$3.02
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) SRNGU
10% owner
Holding Value $207M 17,325,000 shares
Last Trade
Sep 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$22.1M 1,925,000 shares
$11.50
$11.97
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) SRNGU
10% owner
Holding Value $230M 19,250,000 shares
Last Trade
Sep 16, 2021 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221M 19,250,000 shares
$11.50
$11.97
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) SRNGU
10% owner
Holding Value $0 0 shares
Last Trade
Sep 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516M 43,125,000 shares
$11.97
$11.97
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $286M 31,590,948 shares
Last Trade
Sep 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.27B 11,534,052 shares
$456.80
$9.05
Soaring Eagle Acquisition
Soaring Eagle Acquisition SRNG
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2021 Sale
$492M 43,125,000 shares
$11.42
$11.42
Soaring Eagle Acquisition - Warrants (23/02/2026)
Soaring Eagle Acquisition - Warrants (23/02/2026) SRNGW
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2021 Sale
$130M 43,125,000 shares
$3.02
$3.02
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)
Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) SRNGU
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2021 Sale
$516M 43,125,000 shares
$11.97
$11.97

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up